(5R)-18-bromooctadec-6-en-5-ol

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (5R)-18-bromooctadec-6-en-5-ol
• 化学式: C₁₈H₃₅BrO
• 分子量: 347.4
• InChiKey: JMSYQNVKXZCKNW-GOSISDBHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.4
• 重原子数：
  20
• 可旋转键数：
  15
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• Hydroxyeicosenoic acid anaglogs
  申请人：Falck R. John

  公开号：US20050038259A1

  公开（公告）日：2005-02-17

  A hydroxyeicosenoic acid analog represented by the following Formula (I), the bond ≡ represents a cis-vinylene group or an ethynylene group; Y represents CH 2 , O or S(O) p wherein p is 0, 1 or 2; m represents an integer of 1 to 4 inclusive; n represents an integer of 0 to 3 inclusive; the sum of m and n is an integer of 3 to 7 inclusive; R 1 represents a C 1-4 alkyl group or a C 3-8 cycloalkyl group; R 2 represents a hydrogen atom or a methyl group; R 3 represents COR 4 , a nitrile group, a halogen atom, a tetrazole group or a thiazolidinedione group; R 4 represents OR 6 , NHR 6 , N(OH)R 6 , NHSO 2 R 5 , glycerol or functionalized glycerols; R 5 represents a C 1-15 alkyl group, a C 6-10 aryl group or a C 7-14 aryl group substituted with alkyl groups, halogens or amino groups; R 6 represents a hydrogen, a C 1-10 alkyl group or a C 1-10 alkyl group substituted with a hydroxyl group, or a pharmaceutically acceptable salt or hydrate thereof. The compounds of the present invention are useful as an elastase release inhibitor.

  一种羟基二十烯酸类似物，由以下公式（I）表示，其中键≡表示顺式乙烯基或乙炔基；Y表示CH2，O或S（O）p，其中p为0，1或2；m表示1到4之间的整数；n表示0到3之间的整数；m和n的总和为3到7之间的整数；R1表示C1-4烷基或C3-8环烷基；R2表示氢原子或甲基基团；R3表示COR4，腈基，卤素原子，四唑基或噻唑烷二酮基；R4表示OR6，NHR6，N（OH）R6，NHSO2R5，甘油或功能化甘油；R5表示C1-15烷基，C6-10芳基或C7-14芳基，被烷基，卤素或氨基取代；R6表示氢，C1-10烷基或C1-10烷基，被羟基取代，或其医药上可接受的盐或水合物。本发明的化合物可用作弹性蛋白酶释放抑制剂。
• Hydroxyfattysulfonic acid analogs
  申请人：Falck R John

  公开号：US20050020680A1

  公开（公告）日：2005-01-27

  A hydroxyfattysulfonic acid analog represented by Formula (I): wherein X is an ethylene group, a vinylene group or an ethynylene group; Y is an ethylene group, a vinylene group, an ethynylene group, OCH 2 or S(O)pCH 2 wherein p is 0, 1 or 2; m is an integer of 1 to 5 inclusive; n is an integer of 0 to 4 inclusive; R 1 is a C 1-8 alkyl group, a C 3-8 cycloalkyl group, a C 1-4 alkyl group substituted with a C 3-8 cycloalkyl group, a C 1-4 alkyl group substituted with an aryl group or a C 1-4 alkyl group substituted with an aryloxy group; R 2 is a hydrogen atom or a methyl group; R 1 and R 2 together with the carbon atom to which they are attached may form a C 3-8 cycloalkyl group; R 3 is a hydrogen atom or a C 2-8 acyl group; R 4 is OR 5 or NHR 6 , wherein R 5 is a hydrogen atom, a C 1-4 alkyl group, an alkali metal, an alkaline earth metal or an ammonium group and R 6 is a hydrogen atom or a C 1-4 alkyl group; or a pharmaceutically acceptable salt or a hydrate thereof. The compounds of the present invention are useful as an elastase release inhibitor.

  一种羟基脂肪磺酸类似物，其化学式表示为（I）：其中X是乙烯基，乙烯基基团或乙炔基团；Y是乙烯基，乙烯基基团，乙炔基团，OCH2或S（O）pCH2，其中p为0，1或2；m为1至5的整数，包括1和5；n为0至4的整数，包括0和4；R1是C1-8烷基，C3-8环烷基，C1-4烷基，其上取代有C3-8环烷基，C1-4烷基，其上取代有芳基或C1-4烷基，其上取代有芳氧基；R2是氢原子或甲基基团；R1和R2与它们连接的碳原子一起可以形成C3-8环烷基；R3是氢原子或C2-8酰基基团；R4是OR5或NHR6，其中R5是氢原子，C1-4烷基，碱金属，碱土金属或铵基团，R6是氢原子或C1-4烷基；或其药学上可接受的盐或水合物。本发明化合物可用作弹性蛋白酶释放抑制剂。
• HYDROXYFATTYSULFONIC ACID ANALOGS
  申请人：TAISHO PHARMACEUTICAL CO., LTD

  公开号：EP1436252A1

  公开（公告）日：2004-07-14
• EP1436252A4
  申请人：——

  公开号：EP1436252A4

  公开（公告）日：2005-02-09
• [EN] HYDROXYFATTYSULFONIC ACID ANALOGS<br/>[FR] ANALOGUES D'ACIDES GRAS HYDROXYSULFONIQUES
  申请人：TAISHO PHARMA CO LTD

  公开号：WO2003024922A1

  公开（公告）日：2003-03-27

  A hydroxyfattysulfonic acid analog represented by Formula (I): wherein X is an ethylene group, a vinylene group or an ethynylene group; Y is an ethylene group, a vinylene group, an ethynylene group, OCH2 or S(O)pCH2 wherein p is 0, 1 or 2; m is an integer of 1 to 5 inclusive; n is an integer of 0 to 4 inclusive;R1 is a C¿1-8? alkyl group, a C3-8 cycloalkyl group, a C1-4 alkyl group substituted with a C3-8 cycloalkyl group, a C1-4 alkyl group substituted with an aryl group or a C1-4 alkyl group substituted with an aryloxy group; R?2¿ is a hydrogen atom or a methyl group; R?1 and R2¿ together with the carbon atom to which they are attached may form a C¿3-8? cycloalkyl group; R?3¿ is a hydrogen atom or a C¿2-8? acyl group; R?4 is OR5 or NHR6¿, wherein R5 is a hydrogen atom, a C¿1-4? alkyl group, an alkali metal, an alkaline earth metal or an ammonium group and R?6¿ is a hydrogen atom or a C¿1-4? alkyl group; or a pharmaceutically acceptable salt or a hydrate thereof. The compounds of the present invention are useful as an elastase release inhibitor.